Pharmacoeconomic evaluation of two kinds of quinolones in the treatment of lower respiratory tract infections
Jianping Wang, Cai Jie
Abstract
Jianping Wang, Cai Jie
Abstract
OBJECTIVE To evaluate the therapeutic efficacy and pharmacoeconomic results of two kinds of quinolones in the treatment of lower respiratory tract infections.METHODS 156 patients with the treatment of lower respiratory tract infections were randomly divided into two groups,who were given gatifloxacin and levofloxiacin respectively.Therapeutic effects were observed and pharmacoeconomic analysis was evaluated. RESULTS The total effective rates of gatifloxacin group and levofloxiacin group were(93.60%) and 91.00%,pharmacoeconomic analysis indicated the levofloxiacin was superior to gatifloxacin.CONCLUSION Pharmacoeconomic analysis indicated the levofloxiacin was superior to gatifloxacin in the treatment of lower respiratory tract infections.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To evaluate the therapeutic efficacy and pharmacoeconomic results of two kinds of quinolones in the treatment of lower respiratory tract infections.METHODS 156 patients with the treatment of lower respiratory tract infections were randomly divided into two groups,who were given gatifloxacin and levofloxiacin respectively.Therapeutic effects were observed and pharmacoeconomic analysis was evaluated. RESULTS The total effective rates of gatifloxacin group and levofloxiacin group were(93.60%) and 91.00%,pharmacoeconomic analysis indicated the levofloxiacin was superior to gatifloxacin.CONCLUSION Pharmacoeconomic analysis indicated the levofloxiacin was superior to gatifloxacin in the treatment of lower respiratory tract infections.
Key concepts: Gatifloxacin, Medicine, Respiratory tract infections, Pharmacoeconomics, Respiratory tract, Therapeutic effect, Internal medicine, Intensive care medicine